Report      Database

    Influenza Vaccines Market & Forecast - Worldwide Analysis

    Date: 14 Nov, 2014              Type: Life Science              Pages: 179

    Influenza Vaccines Market & Forecast - Worldwide Analysis
    • Electronic Access - Single User License
      $1,490.00
    • CD-ROM Mail Delivery
      $1,590.00
    • Hard-copy Mail Delivery
      $1,640.00
    • Electronic Access - Multi User License
      $2,490.00

    Get 10% Free Customization in this Report

    Global insulin pump market is expected to cross US$ 8 Billion by 2024. The expansion of diabetes management policy and addition of diabetes technology across the world, the market for insulin pump will cultivate positive outlook in an anticipated year. With the help of insulin pump patients manage their diabetes with high degree of efficiency without frequent support from physician. In addition, there are lots of assessments has been done so far associated with insulin pump and it shows quite favorable results.

     

    Request a free sample copy of the report: http://www.renub.com/contactus.php


    United States captures more than half of the Insulin Pump Global Market

    The better implementation of public & private reimbursement policy regarding insulin pump makes United States world’s largest insulin pump market. Moreover people in United States are well informed about insulin pump and they know it can be used to manage severe diabetes complication either occurred by type 1 diabetes or type 2 diabetes. 


    Germany has the Largest Number of Insulin Pump User in Europe

    Germany records the highest number of insulin pump user due its overall population and relatively more number of type 1 diabetes patients in Europe. 


    Reimbursement Policy Analysis 

    Reimbursement policy of USA and Australia is considered to be one of the best compared to all the other 11 countries studied in the report.  

    Global Insulin Pump Market, Users, Forecast, Reimbursement Policy (Countries: US, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, UK & Japan) Clinical Trials, Training Model, Companies Analysis is the 2nd edition published by Renub Research on Insulin Pump Market. This 240 page report with 123 Figures and 12 Tables provides a detailed and comprehensive insight of the Global Insulin Pump Market. 


    Scope of the Report

    •    Insulin Pump Market & Forecast: We have defined insulin pump market and volume of user of 11 countries. Market data from 2010 to 2016 and Forecast from 2017 to 2024.

    •    Reimbursement Policy: Report provides details of separate reimbursement policy for 11 countries including Insulin Pumps, Diabetes Supplies (Blood Glucose Devices, Test Strips, Lancets, Disposable Needles, Syringe, Ketone Urine Testing Strips, Pen Delivery etc)

    •    Training Models: This topic shows through flow chart method, how a company provides training. This segment companies Training program for its staff includes physicians, Certified Diabetes Educators (including nurse educators, dietitians and exercise physiologists) and support staff with expertise in insulin pump therapy and Training program for patients have been described through flow chart method. In total 4 companies Medtronic, Insulet Corporation, Animas Corporation & Tandem Diabetes Care Training program has been studied in the report.    

    •    Differentiation Points of Insulin Pump Products: This topic discusses the Advantages and Drawbacks of the following insulin pumps: Animas Vibe, Medtronic 530G with Enlite, Insulet OmniPod, Tandem t:slim, Roche Accu-Chek Combo.

    •    Clinical Trials of Insulin Pumps: Report captures details of clinical trials results for companies on Insulin Pumps. The report captures details of the following companies Medtronic, Insulet Corporation, Tandem Diabetes Care, Roche and Animas Corporation.

    •    Companies Analysis: All the 3 companies have been covered from the following points: Overview, Product Details, Insulin Pump Sales Analysis and Latest Development & Trends in their insulin pumps. The three companies studied in the report are as follows: Medtronic, Insulet Corporation and Tandem Diabetes Care.

    •    Growth Drivers for Insulin Pumps: This topic studies the factors which is helping the Insulin Pump industry to grow.  

    •    Challenges for Insulin Pumps: This industry shows the problems being faced by the insulin Pump industry.


    Key Companies Covered

    1.    Medtronic 
    2.    Insulet Corporation 
    3.    Tandem Diabetes Care  

    Countries Covered

    1.    United States
    2.    Canada 
    3.    Germany 
    4.    Australia 
    5.    France 
    6.    Netherlands
    7.    Switzerland
    8.    Sweden 
    9.    Israel 
    10.    United Kingdom
    11.    Japan

     

     

    Content from Old Report is given below: 
    The user can buy this report in Chapters from Purchase by Chapter section given above 

     

    Influenza Vaccines Market Analysis 

    The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of administration are the main drivers to galvanized Influenza vaccines market. 
     
    Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010 primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu epidemic. 

    United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5 to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage. 

    In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the highest sales figures and likely to maintain leadership position in the Seasonal Influenza vaccines market.

    This is 2nd edition report on Influenza Vaccines by Renub Research. Research study titled “Influenza Vaccines Market & Forecast - Worldwide Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World Influenza Vaccines landscape. This 179 page report with 140 Figures and 7 Tables examines the following segments for Influenza Vaccines Market.

    • Worldwide Influenza vaccines market (2009 - 2019)

    • Worldwide Seasonal Influenza vaccines market has been covered from (2009 – 2019)
    • Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009 – 2011)

    • Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019) 

    • Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)

    • Top 30 countries Seasonal Influenza vaccines market (2008 – 2019)   

    • Top Brands Seasonal Influenza vaccines (Fluarix/Flulaval, Afluria/Fluvax, FluMist/Fluenz, Influvac, Fluvirin / Flucelvax, Fluzone)  Sales Performance & Forecast

    • Top Merger & Acquisition deals in Influenza Vaccines Market

    • Key drivers of growth in the Worldwide Influenza Vaccines Market 

    • Key challenges faces by Influenza Vaccines Market
     
    All the 30 Countries Studied in the Report are as Follows

    1. United States
    2. Japan
    3. China
    4. India
    5. Brazil
    6. Netherlands
    7. Germany
    8. France
    9. Italy
    10. Spain
    11. Denmark
    12. Sweden
    13. Portugal
    14. Luxembourg
    15. Lithuania
    16. United Kingdom
    17. Poland
    18. Norway
    19. Romania
    20. Estonia
    21. Finland
    22. Hungary
    23. Ireland
    24. Iceland
    25. Latvia
    26. Malta
    27. Slovakia
    28. Slovenia
    29. Australia
    30. New Zealand

    Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows

    1. Fluarix / Flulaval
    2. Afluria/Fluvax
    3. FluMist/Fluenz
    4. Influvac
    5. Fluvirin / Flucelvax 
    6. Fluzone 

    Data Sources 

    This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
     
    Primary sources include industry surveys and telephone interviews with industry experts. 

    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. 

    1. Executive Summary

    2. Worldwide Influenza Vaccines Market & Forecast
    2.1 Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    2.2 Merger and Acquisition in Influenza Vaccines Market

    3. Worldwide – Seasonal Influenza Vaccines Market & Forecast

    4. Worldwide – Swine Flu (H1N1) Influenza Vaccines Market

    5. Worldwide Influenza Vaccines Market Share & Forecast
    5.1 Segment wise – Influenza Vaccines Market Share & Forecast
    5.2 Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share & Forecast
    5.3 Countries wise – Seasonal Influenza Vaccines Market Share & Forecast

    6. Geographical Segmentation – Seasonal Influenza Vaccines Market & Vaccination Coverage (2008 – 2019) 
     
    6.1 United States
    6.1.1 United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.1.2 United States – Seasonal Influenza Vaccines Market & Forecast

    6.2 Japan
    6.2.1 Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.2.2 Japan – Seasonal Influenza Vaccines Market & Forecast

    6.3 China
    6.3.1 China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.3.2 China – Seasonal Influenza Vaccines Market & Forecast

    6.4 India
    6.4.1 India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.4.2 India – Seasonal Influenza Vaccines Market & Forecast

    6.5 Brazil
    6.5.1 Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.5.2 Brazil – Seasonal Influenza Vaccines Market & Forecast

    6.6 Netherlands
    6.6.1 Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.6.2 Netherlands – Seasonal Influenza Vaccines Market & Forecast

    6.7 Germany
    6.7.1 Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.7.2 Germany – Seasonal Influenza Vaccines Market & Forecast

    6.8 France
    6.8.1 France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.8.2 France – Seasonal Influenza Vaccines Market & Forecast

    6.9 Italy
    6.9.1 Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.9.2 Italy – Seasonal Influenza Vaccines Market & Forecast

    6.10 Spain
    6.10.1 Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.10.2 Spain – Seasonal Influenza Vaccines Market & Forecast

    6.11 Denmark
    6.11.1 Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.11.2 Denmark – Seasonal Influenza Vaccines Market & Forecast

    6.12 Sweden
    6.12.1 Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.12.2 Sweden – Seasonal Influenza Vaccines Market & Forecast

    6.13 Portugal
    6.13.1 Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.13.2 Portugal – Seasonal Influenza Vaccines Market & Forecast

    6.14 Luxembourg
    6.14.1 Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.14.2 Luxembourg – Seasonal Influenza Vaccines Market & Forecast

    6.15 Lithuania
    6.15.1 Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.15.2 Lithuania – Seasonal Influenza Vaccines Market & Forecast

    6.16 United Kingdom
    6.16.1 United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.16.2 United Kingdom – Seasonal Influenza Vaccines Market & Forecast

    6.17 Poland
    6.17.1 Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.17.2 Poland – Seasonal Influenza Vaccines Market & Forecast

    6.18 Norway
    6.18.1 Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.18.2 Norway – Seasonal Influenza Vaccines Market & Forecast

    6.19 Romania
    6.19.1 Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.19.2 Romania – Seasonal Influenza Vaccines Market & Forecast

    6.20 Estonia
    6.20.1 Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.20.2 Estonia – Seasonal Influenza Vaccines Market & Forecast

    6.21 Finland
    6.21.1 Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.21.2 Finland – Seasonal Influenza Vaccines Market & Forecast

    6.22 Hungary
    6.22.1 Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.22.2 Hungary – Seasonal Influenza Vaccines Market & Forecast

    6.23 Ireland
    6.23.1 Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.23.2 Ireland – Seasonal Influenza Vaccines Market & Forecast

    6.24 Iceland
    6.24.1 Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.24.2 Iceland – Seasonal Influenza Vaccines Market & Forecast

    6.25 Latvia
    6.25.1 Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.25.2 Latvia – Seasonal Influenza Vaccines Market & Forecast

    6.26 Malta
    6.26.1 Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.26.2 Malta – Seasonal Influenza Vaccines Market & Forecast

    6.27 Slovakia
    6.27.1 Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.27.2 Slovakia – Seasonal Influenza Vaccines Market & Forecast

    6.28 Slovenia
    6.28.1 Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.28.2 Slovenia – Seasonal Influenza Vaccines Market & Forecast

    6.29 Australia
    6.29.1 Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.29.2 Australia – Seasonal Influenza Vaccines Market & Forecast

    6.30 New Zealand
    6.30.1 New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    6.30.2 New Zealand – Seasonal Influenza Vaccines Market & Forecast

    7. Worldwide – Seasonal Influenza Vaccine Brand Sales & Forecast
    7.1 Fluarix / Flulaval – Sales Performance & Forecast
    7.2 Afluria/Fluvax – Sales Performance & Forecast
    7.3 FluMist/Fluenz – Sales Performance & Forecast
    7.4 Influvac (Now Acquired by Abbott) – Sales Performance & Forecast
    7.5 Fluvirin / Flucelvax  – Sales Performance & Forecast
    7.6 Fluzone – Sales Performance & Forecast

    8. Growth Drivers in the Influenza Vaccines Market
    8.1 Transforming Vaccine Technologies
    8.2 Continuous Focus on Effective Communication Strategies
    8.3 Vaccines most Cost Effective Means of Disease Prevention
    8.4 Scientific & Technological Breakthroughs
    8.5 Promote Education, Training, & Information exchange on Seasonal Influenza & Vaccination in European Countries

    9. Challenges for Influenza Vaccine Market
    9.1 Obstacle to Best Possible use of Licensed Vaccines
    9.1.1 Economic Obstacles
    9.1.2 Technical Obstacles
    9.1.3 Cultural Obstacles
     
    9.2 Difficulty of Influenza Vaccine Development & Approval System
    9.2.1 General Technical Barriers
    9.2.2 Economic Barriers
    9.2.3 Legal Barriers
    9.2.4 Regulatory Barriers
     
    9.3 Reducing the Timeline for Vaccine Development
     
    9.4 Problem Faced by Healthcare Workers in Immunization 

    List of Figures:

    Figure 2 1: Worldwide – Influenza Vaccines Market (Million US$), 2009 – 2013
    Figure 2 2: Worldwide – Forecast for Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 2 3: Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2009 – 2013
    Figure 2 4: Worldwide – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2014 – 2019

    Figure 3 1: Worldwide – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013
    Figure 3 2: Worldwide – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

    Figure 4 1: Worldwide – Swine Flu (H1N1) Influenza Vaccines Market (Million US$), 2009 – 2011

    Figure 5 1: Segment wise – Influenza Vaccines Market Share (Percent), 2009 – 2013
    Figure 5 2: Segment wise – Forecast for Influenza Vaccines Market Share (Percent), 2014 – 2019

    Figure 6 1: United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2009 – 2013
    Figure 6 2: United States – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 3: United States – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013
    Figure 6 4: United States – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 5: Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 6: Japan – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 7: Japan – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 8: Japan – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 9: China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008–2013
    Figure 6 10: China – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 11: China – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 12: China – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 13: India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 14: India – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 15: India – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 16: India – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 17: Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 18: Brazil – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 19: Brazil – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 20: Brazil – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 21: Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 22: Netherlands – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 23: Netherlands – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 24: Netherlands – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 25: Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 26: Germany – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 27: Germany – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 28: Germany – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 29: France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 30: France – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 31: France – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 32: France – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 33: Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 34: Italy – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 35: Italy – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 36: Italy – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 37: Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 38: Spain – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 39: Spain – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 40: Spain – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 41: Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 42: Denmark – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 43: Denmark – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 44: Denmark – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 45: Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 46: Sweden – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 47: Sweden – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 48: Sweden – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 49: Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 50: Portugal – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 51: Portugal – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 52: Portugal – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 53: Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 54: Luxembourg – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 55: Luxembourg – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 56: Luxembourg – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 57: Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 58: Lithuania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 59: Lithuania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 60: Lithuania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 61: United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 62: United Kingdom – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 63: United Kingdom – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 64: United Kingdom – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 65: Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 66: Poland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 67: Poland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 68: Poland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 69: Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 70: Norway – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 71: Norway – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 72: Norway – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 73: Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 74: Romania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 75: Romania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 76: Romania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 77: Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 78: Estonia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 79: Estonia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 80: Estonia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 81: Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 82: Finland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 83: Finland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 84: Finland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 85: Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 86: Hungary – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 87: Hungary – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 88: Hungary – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 89: Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008–2013
    Figure 6 90: Ireland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 91: Ireland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 92: Ireland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 93: Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 94: Iceland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 95: Iceland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 96: Iceland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 97: Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 98: Latvia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 99: Latvia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 100: Latvia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 101: Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 102: Malta – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 103: Malta – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 104: Malta – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 105: Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 106: Slovakia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 107: Slovakia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 108: Slovakia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 109: Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 110: Slovenia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 111: Slovenia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 112: Slovenia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 113: Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 114: Australia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 115: Australia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 116: Australia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019
    Figure 6 117: New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 – 2013
    Figure 6 118: New Zealand – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 – 2019
    Figure 6 119: New Zealand – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013
    Figure 6 120: New Zealand – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

    Figure 7 1: Worldwide – Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2007 – 2013
    Figure 7 2: Worldwide – Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
    Figure 7 3: Worldwide – Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2010 – 2013
    Figure 7 4: Worldwide – Forecast for Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
    Figure 7 5: Worldwide – Flumist/ Fluenz Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013
    Figure 7 6: Worldwide – Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Sales (Million US$), 2014 – 2019
    Figure 7 7: Worldwide – Influvac Seasonal Infuenza Vaccine Sales (Million US$), 2007 – 2009
    Figure 7 8: Worldwide – Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2010 – 2013
    Figure 7 9: Worldwide – Forecast for Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2014 – 2019
    Figure 7 10: Worldwide – Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013
    Figure 7 11: Worldwide – Forecast for Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2014 – 2019

    List of Tables:

    Table 2 1: Worldwide – Merger and Acquisition in Influenza Vaccines Market (Million US$), 2005 – 2011

    Table 5 1: Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2009 – 2013
    Table 5 2: Countries wise – Forecast for Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2014 – 2019
    Table 5 3: Countries wise – Seasonal Influenza Vaccines Market Share (Percent), 2009 – 2013
    Table 5 4: Countries wise – Forecast for Seasonal Influenza Vaccines Market Share (Percent), 2014 – 2019

    Table 8 1: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations
    Table 8 2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009 

    • Description
      Price
    • Chapter 1 & 2     Pages : 9
      $250
    • Chapter 3     Pages : 2
      $150
    • Chapter 4     Pages : 1
      $100
    • Chapter 5     Pages : 7
      $375
    • Chapter 6     Pages : 102
      $900
    • Chapter 7     Pages : 11
      $250
    • Chapter 8     Pages : 16
      $200
    • Chapter 9     Pages : 10
      $100

    Related Products